Two new 13-hydroxylated milbemycin metabolites from the genetically engineered strain Streptomyces avermitilis AVE-H39

J Asian Nat Prod Res. 2021 Sep;23(9):837-843. doi: 10.1080/10286020.2020.1803294. Epub 2020 Aug 27.

Abstract

Two new milbemycin metabolites, 13α-hydroxymilbemycin β13 (1) and 26-methyl-13α-hydroxymilbemycin β13 (2), were isolated from the fermentation broth of a genetically engineered strain Streptomyces avermitilis AVE-H39. Their structures were determined by the comprehensive spectroscopic data, including 1 D, 2 D NMR, MS spectral analysis and the comparison with data from the literature. Compounds 1 and 2 not only exhibited potent acaricidal activities against Tetranychus cinnabarinus, but also had nematocidal activity against Bursaphelenchus xylophilus.

Keywords: Genetically engineered strain; acaricidal activity; nematocidal activity; new milbemycins; structure elucidation.

MeSH terms

  • Macrolides / pharmacology
  • Molecular Structure
  • Streptomyces* / genetics

Substances

  • Macrolides
  • moxidectin

Supplementary concepts

  • Streptomyces avermitilis